Cargando…
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
CD44H is the principal cell surface receptor for hyaluronate, which is a major glycosaminoglycan of the extracellular matrix. Expression of CD44H is enhanced in a variety of malignant tumors and correlates with tumor aggressiveness, supporting the notion that interaction between CD44H and hyaluronat...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119319/ https://www.ncbi.nlm.nih.gov/pubmed/1500863 |
Ejemplares similares
-
Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021) -
Distinct effects of two CD44 isoforms on tumor growth in vivo
Publicado: (1991) -
Serological Evaluation of Soluble CD44 in Renal Cancer
por: Kan, Masaharu, et al.
Publicado: (1996) -
Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface
por: Päll, Taavi, et al.
Publicado: (2011) -
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
por: Lim, Sungsu, et al.
Publicado: (2018)